Eight States to Vote on Legalizing Marijuana for Recreational or Medical Purposes in November; 89% of U.S. Voters Say Medical Marijuana Should Be Legal

Medical Marijuana, Inc. (OTC: MJNA) is pleased to announce that the current national political landscape favors legalizing medical marijuana, with both the Democrat and Republican Presidential nominees Hillary Clinton and Donald Trump in support for laws that allow legal access to medical marijuana. In addition, eight states will be voting on legalizing marijuana for recreational or medical purposes on November 8, 2016.

Democratic Presidential nominee Hillary Clinton recently told ABC News’ Good Morning America that she is “100 percent in favor of medical marijuana for medical use” and supports more research into marijuana’s medical benefits. If elected in November, Clinton also plans to reschedule marijuana from a Schedule I to a Schedule II substance, according to her campaign, which would mean acceptance at the federal level that marijuana has uses for medical treatment. Republican Presidential nominee Donald Trump said that he “100 percent backed legal medical cannabis” in a Feb. 10, 2016 interview on Bill O’Reilly’s Fox News show and that he personally knows people with serious medical problems that medical marijuana has helped.

“The current political climate and mindset of a majority of Americans are favorable in terms of medical marijuana,” said Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana Inc. “Our company’s goal is ‘access for all’ and we’re optimistic that medical marijuana will soon be legal throughout the entire U.S. and that the federal government will soon acknowledge what the medical community and patients have known for years: that cannabis has therapeutic value and should not be classified among some of the world’s most dangerous drugs.”

On November 8, 2016, eight states will have cannabis-related ballot initiatives, voting for legalizing marijuana for either medicinal or recreational purposes. Legalization for recreational use will be on the ballot in California, Nevada, Arizona, Massachusetts and Maine, while legalization for medical use will be on the ballot in Florida, Missouri and Arkansas.

A recent 24/7 Wall St. article predicts the next 14 states most likely to legalize recreational marijuana based on each state’s current marijuana laws and legislative processes. According to the article, the next states most likely to repeal marijuana prohibition are those that already allow marijuana use for medical reasons, allow ballot initiatives through which statutes and constitutional amendments can be proposed by voters and have decriminalized possession of small amounts of marijuana.

“We’re in the midst of a global cannabis revolution, with more states coming aboard soon,” added Dr. Titus. “We’ve reached a tipping point in the U.S. in terms of states legalizing medical marijuana, which we believe will lead to real marijuana reform at the federal level.”

Currently, medical marijuana is legal in 50 percent of the United States and according to a June 2016 Quinnipiac University poll, 89 percent of voters in the U.S. believe that adults should be allowed legal access to medical marijuana when a physician prescribes it.

“Also noteworthy in many medical marijuana-legal states is that we are now seeing an expansion of the number of potential allowable indications for doctors to recommend medicinal cannabis to patients,” added Titus. “For instance, the two most recent states to legalize medical marijuana – Ohio and Pennsylvania – slated 21 and 18 medical conditions allowed for patients to qualify for medical marijuana under their respective programs. The greater the number of medical indications that states allow for qualification to receive medical marijuana, the greater the number of residents will receive access and benefit.”

Medical Marijuana, Inc.’s current investments are in both the marijuana services and industrial hemp cannabidiol (CBD) industries; industrial hemp-based products are available to ship to all 50 states, districts, territories and more than 40 countries. As evidenced by the Company’s international distribution of hemp CBD retail products to Brazil, Mexico and Paraguay by way of government-issued import permits, the global demand for legal cannabis products is on the rise. Medical Marijuana Inc. is also focused on investments that are developing cannabis-based pharmaceutical drug development for global distribution.

When Federal legalization of marijuana occurs in the U.S., Medical Marijuana, Inc. will easily transition into operational expansion of marijuana-derived product production, marketing and distribution.

For more information on the key components of the legal cannabis industry, visit Medicial Marijuana, Inc.’s educational page on the company’s website.


Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070

Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA  (888-682- 6562 )

Investor Relations Contact:
EquiNet, LLC
Toll Free:  (877) 964.6463
Office/Direct: (858) 264-6500

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement,  click here . Shareholders are also encouraged to visit the  Medical Marijuana, Inc. Shop  for discounted products.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.